TMCnet News

Research and Markets: Orthobiologics Market Report 2013-2019: Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others
[March 18, 2014]

Research and Markets: Orthobiologics Market Report 2013-2019: Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/sj346m/orthobiologics) has announced the addition of the "Orthobiologics Market Report 2013-2019: Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others" report to their offering.

The global orthobiologics market was valued at USD 3,754.6 million in 2012 and is expected to grow at a CAGR of 5.9% from 2013 to 2019 to reach at an estimated value of USD 5,519.9 million in 2019.

This research report on orthobiologics provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of orthobiologics on the basis of different orthobiologic products and applications. The product segment comprises allografts, demineralized bone matrix (DBM), bone morphogenetic proteins (BMPs), viscosupplementation, synthetic bone graft substitutes, stem cell based products and machined bone. The application segment is classified into spinal fusion, trauma and reconstructive surgeries.

Orthobiology is a branch of science that develops bone and tissue replacement materials for skeletal andtissue healing. Orthobiologics has been gaining popularity since it provides accelerated healing, faster recovery and reduction in number of hospital visits. A rise in the incidence of arthritis and geriatric population has triggered the growth of this market.



Moreover, an increase in the obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and rising participation in sports related activities has considerably augmented the growth of this market.

Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments, in terms of USD million, using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.


Scope of the Report

Products

- Allografts

- Machined Bones

- Demineralized Bone Matrix (DBM)

- Bone Morphogenetic Proteins (BMPs)

- Viscosupplementation

- Stem Cell Therapy

- Synthetic Bone Substitutes

Applications

- Spinal Fusion

- Trauma

- Reconstructive Surgery

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Global Orthobiologics Market, by Product

Chapter 5 Global Orthobiologics Market, by Application

Chapter 6 Global Orthobiologics Market, by Geography

Chapter 7 Global Orthobiologics Market Share Analysis

Chapter 8 Recommendations

Chapter 9 Company Profiles

  • Alphatec Spine, Inc.
  • Bacterin International, Inc.
  • Biomet, Inc.
  • DePuy Synthes, Inc. (A Johnson & Johnson Company)
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Orthofix Holdings, Inc.
  • Regeneration Technologies, Inc.
  • Sanofi
  • Stryker Corporation
  • Wright Medical Technology, Inc.
  • Zimmer Holdings, Inc.

For more information visit http://www.researchandmarkets.com/research/sj346m/orthobiologics


[ Back To TMCnet.com's Homepage ]